IL315871A - Aqueous composition - Google Patents
Aqueous compositionInfo
- Publication number
- IL315871A IL315871A IL315871A IL31587124A IL315871A IL 315871 A IL315871 A IL 315871A IL 315871 A IL315871 A IL 315871A IL 31587124 A IL31587124 A IL 31587124A IL 315871 A IL315871 A IL 315871A
- Authority
- IL
- Israel
- Prior art keywords
- salts
- buffer agents
- esters
- examples
- acid buffer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022050275 | 2022-03-25 | ||
| PCT/JP2023/011739 WO2023182480A1 (ja) | 2022-03-25 | 2023-03-24 | 水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315871A true IL315871A (en) | 2024-11-01 |
Family
ID=88101709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315871A IL315871A (en) | 2022-03-25 | 2023-03-24 | Aqueous composition |
Country Status (14)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026130361A1 (zh) * | 2024-12-17 | 2026-06-25 | 沈阳兴齐眼药股份有限公司 | 药物组合物、其制备方法及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4806956B2 (ja) * | 2004-04-20 | 2011-11-02 | 大正製薬株式会社 | 点眼用液剤 |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| JP2009078977A (ja) * | 2007-09-25 | 2009-04-16 | Japan Health Science Foundation | 心筋の小胞体ストレス抑制剤 |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| US8962686B2 (en) * | 2010-04-28 | 2015-02-24 | The Chinese University Of Hong Kong | Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| EP2698155A1 (en) * | 2012-08-16 | 2014-02-19 | Lunamed AG | Pharmaceutical unit dosage form comprising 4-phenylbutyric acid |
| PT3593817T (pt) | 2017-03-06 | 2024-12-17 | Tsubota Lab Inc | Composição para a utilização na prevenção ou supressão da miopia |
| EP3603642B1 (en) * | 2017-03-27 | 2024-01-10 | Alcon Inc. | Pharmaceutical preparation |
| CN113164421A (zh) | 2018-12-18 | 2021-07-23 | 参天制药株式会社 | 含有4-苯基丁酸的老视的治疗或预防剂 |
| CN111024960B (zh) * | 2019-12-27 | 2023-02-17 | 广州阳普医疗科技股份有限公司 | 用于高血压血样检测的添加剂、试剂盒和应用 |
-
2023
- 2023-03-24 AU AU2023240729A patent/AU2023240729A1/en active Pending
- 2023-03-24 TW TW112111197A patent/TW202400133A/zh unknown
- 2023-03-24 IL IL315871A patent/IL315871A/en unknown
- 2023-03-24 EP EP23775073.2A patent/EP4483867A4/en active Pending
- 2023-03-24 CN CN202380029644.0A patent/CN118973561A/zh active Pending
- 2023-03-24 MX MX2024011634A patent/MX2024011634A/es unknown
- 2023-03-24 KR KR1020247035255A patent/KR20240159636A/ko active Pending
- 2023-03-24 JP JP2024509249A patent/JPWO2023182480A1/ja active Pending
- 2023-03-24 US US18/847,501 patent/US20250213510A1/en active Pending
- 2023-03-24 PE PE2024002054A patent/PE20250746A1/es unknown
- 2023-03-24 WO PCT/JP2023/011739 patent/WO2023182480A1/ja not_active Ceased
- 2023-03-24 CA CA3254664A patent/CA3254664A1/en active Pending
- 2023-03-24 MA MA67594A patent/MA67594B1/fr unknown
-
2024
- 2024-09-23 CL CL2024002831A patent/CL2024002831A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4483867A1 (en) | 2025-01-01 |
| WO2023182480A1 (ja) | 2023-09-28 |
| US20250213510A1 (en) | 2025-07-03 |
| KR20240159636A (ko) | 2024-11-05 |
| CN118973561A (zh) | 2024-11-15 |
| MX2024011634A (es) | 2024-09-30 |
| MA67594B1 (fr) | 2026-01-30 |
| CL2024002831A1 (es) | 2025-01-24 |
| MA67594A1 (fr) | 2025-07-31 |
| EP4483867A4 (en) | 2026-06-24 |
| TW202400133A (zh) | 2024-01-01 |
| JPWO2023182480A1 (cg-RX-API-DMAC7.html) | 2023-09-28 |
| AU2023240729A1 (en) | 2024-10-03 |
| CA3254664A1 (en) | 2025-07-03 |
| PE20250746A1 (es) | 2025-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053577L (no) | Clindamycin phosphate foam | |
| EP0937395B1 (en) | Disinfecting and sterilizing concentrate containing an aromatic dialdehyde and a neutral ph buffering system | |
| JP2011098960A (ja) | 水性組成物 | |
| MX2025007492A (es) | Compuestos lipidicos y composiciones de nanoparticulas lipidicas | |
| PL342822A1 (en) | Pharmacological compositions containing sodium {[3-(amino-1,2-dipxyethyl)-2-ethyl-1-phenylmethyl)-1h-idol-4-yl]-4-oxy} acetate as a phosphpolipase inhibitor | |
| PE20080766A1 (es) | Sales de benzimidazolil piridil eteres y formulaciones que las contienen | |
| JP2011026350A5 (cg-RX-API-DMAC7.html) | ||
| ZA200005238B (en) | Pyrrolidines as inhibitors of neuraminidases. | |
| EP3506947A1 (en) | Pharmaceutical formulations of regadenoson | |
| JP2018044013A (ja) | 水性組成物 | |
| US20120157496A1 (en) | Stabilized and preserved ketotifen ophthalmic compositions | |
| TW202400133A (zh) | 水性組成物 | |
| JP2019210288A (ja) | 水性液剤 | |
| JP2003213462A (ja) | 気化性固形防錆剤 | |
| TH2301006513A (th) | องค์ประกอบนิโคตินที่ถูกรองรับ | |
| MXPA05002719A (es) | Formula de una solucion liquida para aplicacion en el oido externo (conducto auditivo externo) como preventivo de la otitis externa. | |
| WO2024010040A1 (ja) | 眼科組成物 | |
| JP2008247828A (ja) | ラタノプロストを含有する水性医薬組成物。 | |
| JPS6056079A (ja) | 金属製容器を用いた含水エアゾ−ル製品の防錆法 | |
| JP2003063963A (ja) | オザグレルナトリウム含有注射液 | |
| JPH03227907A (ja) | 皮膚化粧料 | |
| JP2002173422A (ja) | 脳室洗浄製剤 | |
| JPS61130223A (ja) | 抗菌性凍結乾燥製剤 | |
| JPS62163689A (ja) | アミノアシラ−ゼ溶液の安定化法 | |
| JPH1088095A (ja) | 固形状接着剤 |